Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD-Reference-Cited by-同舟云学术

Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD

Published:2016-07-20 Issue:1 Volume:16 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Beier Jutta,Pujol Helena,Seoane Beatriz,Jimenez Eulalia,Astbury Carol,Massana Eric,Ruiz Sandrine,de Miquel Gonzalo

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-016-0266-5.pdf

Reference27 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2016. http://goldcopd.org/gold-reports/ . Accessed 24 Apr 2016.

2. AstraZeneca PLC. Summary of product characteristics Duaklir® Genuair™ 340 μg inhalation powder 2014. http://www.medicines.org.uk/emc/medicine/29652 . Accessed 11 Mar 2015

3. GlaxoSmithKline. Anoro® Ellipta® Summary of Product Characteristics 2015. https://www.medicines.org.uk/emc/medicine/28949/ . Accessed 8 May 2015.

4. Novartis Pharmaceuticals Ltd. Ultibro® Breezhaler® Summary of Product Characteristics 2015. http://www.medicines.org.uk/emc/medicine/29533 . Accessed 8 May 2015.

5. Boehringer Ingelheim Limited. Spiolto Respimat® Summary of Product Characteristics 2015. https://www.medicines.org.uk/emc/medicine/30495 . Accessed 24 Nov 2015.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update;Expert Opinion on Pharmacotherapy;2023-11-15

2. Current Perspectives of Pharmacotherapies for COPD;Respiratory Care;2023-06-23

3. Asthma and COPD: A Focus on β-Agonists – Past, Present and Future;Handbook of Experimental Pharmacology;2023

4. New drugs under development for COPD;Minerva Medica;2022-07

5. Drivers of absolute systemic bioavailability after oral pulmonary inhalation in humans;European Journal of Pharmaceutics and Biopharmaceutics;2021-07